These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 19175849)

  • 21. Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism.
    Tagawa M; Takeuchi S; Chinushi M; Saeki M; Taniguchi Y; Nakamura Y; Ohno H; Kitazawa K; Aizawa Y
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1121-8. PubMed ID: 17725756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-admission CHADS2 score is related to severity and outcome of stroke.
    Sato S; Yazawa Y; Itabashi R; Tsukita K; Fujiwara S; Furui E
    J Neurol Sci; 2011 Aug; 307(1-2):149-52. PubMed ID: 21570092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV; Panaccio MP; Cummins G; Tu N
    Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Holter monitoring in the diagnosis of stroke mechanism.
    Shafqat S; Kelly PJ; Furie KL
    Intern Med J; 2004 Jun; 34(6):305-9. PubMed ID: 15228390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice.
    Laguna P; Martín A; Del Arco C; Millán I; Gargantilla P;
    Acad Emerg Med; 2005 Sep; 12(9):828-34. PubMed ID: 16141016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation.
    Suzuki S; Sagara K; Otsuka T; Kano H; Matsuno S; Takai H; Uejima T; Oikawa Y; Koike A; Nagashima K; Kirigaya H; Yajima J; Tanabe H; Sawada H; Aizawa T; Yamashita T
    Am J Cardiol; 2013 Jun; 111(11):1602-7. PubMed ID: 23499279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological abnormalities occur prior to the development of clinical episodes of atrial fibrillation: observations from human epicardial mapping.
    Kanagaratnam P; Kojodjojo P; Peters NS
    Pacing Clin Electrophysiol; 2008 Apr; 31(4):443-53. PubMed ID: 18373763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
    Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
    Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
    Boriani G; Santini M; Lunati M; Gasparini M; Proclemer A; Landolina M; Padeletti L; Botto GL; Capucci A; Bianchi S; Biffi M; Ricci RP; Vimercati M; Grammatico A; Lip GY;
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):182-8. PubMed ID: 22373906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
    Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
    Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.
    Martinek M; Aichinger J; Nesser HJ; Ziegler PD; Purerfellner H
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):818-23. PubMed ID: 17573835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
    Thomson R; Eccles M; Wood R; Chinn DJ
    Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis.
    Ruigómez A; Johansson S; Wallander MA; Edvardsson N; García Rodríguez LA
    Int J Cardiol; 2009 Aug; 136(2):186-92. PubMed ID: 18625526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors, atrial fibrillation and thromboembolic events.
    Novo G; Mansueto P; La Franca ML; Di Leo R; Di Rosa S; Fazio G; Mansueto S; Ferrara F; Novo S
    Int Angiol; 2008 Oct; 27(5):433-8. PubMed ID: 18974708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving stroke risk stratification in atrial fibrillation.
    Lip GY; Halperin JL
    Am J Med; 2010 Jun; 123(6):484-8. PubMed ID: 20569748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation.
    Abu-Assi E; Otero-Raviña F; Allut Vidal G; Coutado Méndez A; Vaamonde Mosquera L; Sánchez Loureiro M; Caneda Villar MC; Fernández Villaverde JM; Maestro Saavedra FJ; González-Juanatey JR;
    Int J Cardiol; 2013 Jun; 166(1):205-9. PubMed ID: 22104995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.